Prognostic or Therapeutic - The Role of Sentinel Lymph Node Biopsy in Contemporary Practice

Kristen E. Rhodin; Georgia M. Beasley; Douglas S. Tyler

doi:10.1001/jamasurg.2022.2054

Prognostic or Therapeutic - The Role of Sentinel Lymph Node Biopsy in Contemporary Practice

Kristen E. Rhodin
, Georgia M. Beasley
, Douglas S. Tyler

Surgery

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	843
Number of pages	1
Journal	JAMA Surgery
Volume	157
Issue number	9
DOIs	https://doi.org/10.1001/jamasurg.2022.2054
State	Published - Sep 2022

ASJC Scopus subject areas

Surgery

Access to Document

10.1001/jamasurg.2022.2054

Cite this

@article{801cd2eab9b14115898b32b4db4025fc,

title = "Prognostic or Therapeutic - The Role of Sentinel Lymph Node Biopsy in Contemporary Practice",

author = "Rhodin, \{Kristen E.\} and Beasley, \{Georgia M.\} and Tyler, \{Douglas S.\}",

note = "Funding Information: reported receiving grants from the National Institutes of Health. Dr Beasley reported receiving clinical trial funding from Istari Oncology, Delcath, Oncosec Medical, Replimune, and Checkmate Pharmaceuticals paid to Duke University and serving one time on the advisory boards for Cardinal Health and Regeneron. Dr Tyler reported receiving royalties from UpToDate outside the submitted work. No other disclosures were reported.",

year = "2022",

month = sep,

doi = "10.1001/jamasurg.2022.2054",

language = "English (US)",

volume = "157",

pages = "843",

journal = "JAMA Surgery",

issn = "2168-6254",

publisher = "American Medical Association",

number = "9",

}

TY - JOUR

T1 - Prognostic or Therapeutic - The Role of Sentinel Lymph Node Biopsy in Contemporary Practice

AU - Rhodin, Kristen E.

AU - Beasley, Georgia M.

AU - Tyler, Douglas S.

N1 - Funding Information: reported receiving grants from the National Institutes of Health. Dr Beasley reported receiving clinical trial funding from Istari Oncology, Delcath, Oncosec Medical, Replimune, and Checkmate Pharmaceuticals paid to Duke University and serving one time on the advisory boards for Cardinal Health and Regeneron. Dr Tyler reported receiving royalties from UpToDate outside the submitted work. No other disclosures were reported.

PY - 2022/9

Y1 - 2022/9

UR - https://www.scopus.com/pages/publications/85135922031

UR - https://www.scopus.com/pages/publications/85135922031#tab=citedBy

U2 - 10.1001/jamasurg.2022.2054

DO - 10.1001/jamasurg.2022.2054

M3 - Comment/debate

C2 - 35921120

AN - SCOPUS:85135922031

SN - 2168-6254

VL - 157

SP - 843

JO - JAMA Surgery

JF - JAMA Surgery

IS - 9

ER -

Prognostic or Therapeutic - The Role of Sentinel Lymph Node Biopsy in Contemporary Practice

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this